InnoCan Pharma Corporation
INNO
Rang in Aktien
#33958
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Aktienkurs
$1.35
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$6.08M
Veränderung (1 Tag)
-3.08%
Veränderung (1 Jahr)
-89.20%
Land
CA
Handel InnoCan Pharma Corporation (INNO)
Kategorie
Healthcare
Kursverlauf für InnoCan Pharma Corporation (INNO)
Höchster Schlusskurs: $1.37 am 2026-10-01
Niedrigster Schlusskurs: $11.93 am 2020-11-01
Niedrigster Schlusskurs: $11.93 am 2020-11-01
Kursverlauf der Aktie von InnoCan Pharma Corporation von 2020 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -38.79% |
| 2025 | -29.02% |
| 2024 | -47.91% |
| 2023 | 42.26% |
| 2022 | -67.12% |
| 2021 | 201.26% |
| 2020 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.31 | 42.59% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $19.19 | -0.09% |
IN
|
